A big blow.
Teva Pharmaceuticals has said it plans to close its Sudocrem production plant in Dublin, with over 100 jobs set to be lost as a result.
The company has told staff at its Baldoyle plant of its plans, which will see the plant close by the end of 2022 with production moving to Bulgaria.
“Yesterday we met with employees at our Baldoyle plant to inform them of the proposed closure of the site, as part of a wider programme to optimise our global manufacturing network," a spokesperson for Teva said.
"We know that this news is disappointing for many, but we’ll do everything we can to support all our affected employees throughout this process.
“We’ll continue to have a strong presence in Ireland through our respiratory manufacturing plant in Waterford in addition to our commercial activities, and we remain fully committed to the Irish market,” he added.
